Blood test study to spot early cancer signal and cancer leftovers
Part of Blood & lymphatic, Brain & nervous system, Cancer, Digestive system, Heart & circulation, Hormones & metabolism, Immune system & allergy, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This observational study checks whether a blood test (a “cfDNA” test) can detect early signs of cancer or small amounts of cancer left after treatment. It may help doctors use a simple blood sample to improve cancer detection and follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older
- If you are in the cancer group: your cancer is newly diagnosed (within 120 days) or it returned after being diagnosed more than 5 years ago
- You must share the details about your cancer type (the allowed types are listed in the study)
- You must not be receiving any cancer treatment right now
- You must not be taking “demethylating” (DNA hypomethylating) medicines
- If you are in the healthy/control group: you have had no cancer diagnosis in the last 5 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a blood test to look for tiny bits of cancer DNA after you finish treatment. It may help doctors know if cancer is still there and guide next steps.
This study collects blood from people with cancer and people without cancer (or with possible cancer) to test whether new blood tests can detect cancer earlier. Your blood samples help researchers evaluate how well these tests work.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
This trial tests a new blood test that may find early signs of cancer in people who have no symptoms. If you join, you'll have a blood draw, and the study will check if the test can catch cancer early.
This study uses a blood test that looks at your platelets and immune cells to find common cancers early, and for certain cancers, to monitor how well treatment is working.
This trial uses a blood test (called cfDNA) to look for early signs of pancreatic cancer. It compares results from people with pancreatic cancer, precancerous changes, non-cancerous pancreatic conditions, and healthy individuals to improve early detection.
Hear when a new Brain Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.